The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gray, J. D.
Right arrow Articles by Horwitz, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gray, J. D.
Right arrow Articles by Horwitz, D. A.
The Journal of Immunology, 1998, 160: 2248-2254.
Copyright © 1998 by The American Association of Immunologists

Generation of an Inhibitory Circuit Involving CD8+ T Cells, IL-2, and NK Cell-Derived TGF-ß: Contrasting Effects of Anti-CD2 and Anti-CD31

J. Dixon Gray, Makoto Hirokawa2, Kazuo Ohtsuka and David A. Horwitz3

Division of Rheumatology and Immunology, Department of Medicine, University of Southern California School of Medicine, Los Angeles, CA 90033

Although the phenomenon of immunosuppression is well established, the mechanisms involved in the generation of lymphocytes with down-regulatory activity are poorly understood. Unlike anti-CD3 antibodies, mitogenic combinations of anti-CD2 antibodies do not stimulate human PBL to produce IgM or IgG. In determining the reason for this difference, we have found that anti-CD2 triggers an inhibitory circuit facilitated by TGF-ß provided by NK cells. Stimulation of PBL with anti-CD2, but not anti-CD3, generated substantial amounts of active TGF-ß. NK cells were found to be a significant source of TGF-ß and were the only lymphocyte population that constitutively produced this cytokine. Anti-CD2 enhanced the production of active TGF-ß by purified NK cells. TGF-ß. After the removal of NK cells or the addition of anti-TGF-ß, anti-CD2 could stimulate Ig production. Anti-TGF-ß had to be added within the first 24 h for a maximal effect. Moreover, a short, overnight exposure of CD8+ T cells to TGF-ß could prime them for suppressor activity provided that IL-2 was also present. Thus, the presence of active TGF-ß coincident with CD8+ T cell activation can condition these cells to mediate down-regulatory activity, and NK cells can serve as the source of this cytokine.




This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
G. Chen, G. Han, J. Wang, R. Wang, R. Xu, B. Shen, J. Qian, and Y. Li
Essential roles of TGF-{beta} in anti-CD3 antibody therapy: reversal of diabetes in nonobese diabetic mice independent of Foxp3+CD4+ regulatory T cells
J. Leukoc. Biol., February 1, 2008; 83(2): 280 - 287.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Das and A. D. Levine
TGF-{beta} Inhibits IL-2 Production and Promotes Cell Cycle Arrest in TCR-Activated Effector/Memory T Cells in the Presence of Sustained TCR Signal Transduction
J. Immunol., February 1, 2008; 180(3): 1490 - 1498.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Deniz, G. Erten, U. C. Kucuksezer, D. Kocacik, C. Karagiannidis, E. Aktas, C. A. Akdis, and M. Akdis
Regulatory NK Cells Suppress Antigen-Specific T Cell Responses
J. Immunol., January 15, 2008; 180(2): 850 - 857.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Zhang, A. Barber, and C. L. Sentman
Chimeric NKG2D Modified T Cells Inhibit Systemic T-Cell Lymphoma Growth in a Manner Involving Multiple Cytokines and Cytotoxic Pathways
Cancer Res., November 15, 2007; 67(22): 11029 - 11036.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Cerboni, A. Zingoni, M. Cippitelli, M. Piccoli, L. Frati, and A. Santoni
Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK- cell lysis
Blood, July 15, 2007; 110(2): 606 - 615.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
M.-L. Cheng, H.-W. Chen, J.-P. Tsai, Y.-P. Lee, Y.-C. Shih, C.-M. Chang, and C.-C. Ting
Clonal restriction of the expansion of antigen-specific CD8+ memory T cells by transforming growth factor-{beta}
J. Leukoc. Biol., May 1, 2006; 79(5): 1033 - 1042.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H.-P. Kim, B.-G. Kim, J. Letterio, and W. J. Leonard
Smad-dependent Cooperative Regulation of Interleukin 2 Receptor {alpha} Chain Gene Expression by T Cell Receptor and Transforming Growth Factor-{beta}
J. Biol. Chem., October 7, 2005; 280(40): 34042 - 34047.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. G. Zheng, J. H. Wang, J. D. Gray, H. Soucier, and D. A. Horwitz
Natural and Induced CD4+CD25+ Cells Educate CD4+CD25- Cells to Develop Suppressive Activity: The Role of IL-2, TGF-{beta}, and IL-10
J. Immunol., May 1, 2004; 172(9): 5213 - 5221.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. G. Zheng, J. H. Wang, M. N. Koss, F. Quismorio Jr., J. D. Gray, and D. A. Horwitz
CD4+ and CD8+ Regulatory T Cells Generated Ex Vivo with IL-2 and TGF-{beta} Suppress a Stimulatory Graft-versus-Host Disease with a Lupus-Like Syndrome
J. Immunol., February 1, 2004; 172(3): 1531 - 1539.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Vigouroux, E. Yvon, H.-J. Wagner, E. Biagi, G. Dotti, U. Sili, C. Lira, C. M. Rooney, and M. K. Brenner
Induction of Antigen-Specific Regulatory T Cells following Overexpression of a Notch Ligand by Human B Lymphocytes
J. Virol., October 15, 2003; 77(20): 10872 - 10880.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
D. A. Horwitz, S. G. Zheng, and J. D. Gray
The role of the combination of IL-2 and TGF-{beta} or IL-10 in the generation and function of CD4+ CD25+ and CD8+regulatory T cell subsets
J. Leukoc. Biol., October 1, 2003; 74(4): 471 - 478.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. M. Rigby, T. Rouse, and E. H. Field
Total lymphoid irradiation nonmyeloablative preconditioning enriches for IL-4-producing CD4+-TNK cells and skews differentiation of immunocompetent donor CD4+ cells
Blood, March 1, 2003; 101(5): 2024 - 2032.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
Z.-Q. Wu, A. Q. Khan, Y. Shen, K. M. Wolcott, W. Dawicki, T. H. Watts, R. S. Mittler, and C. M. Snapper
4-1BB (CD137) Differentially Regulates Murine In Vivo Protein- and Polysaccharide-Specific Immunoglobulin Isotype Responses to Streptococcus pneumoniae
Infect. Immun., January 1, 2003; 71(1): 196 - 204.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. G. Zheng, J. D. Gray, K. Ohtsuka, S. Yamagiwa, and D. A. Horwitz
Generation Ex Vivo of TGF-{beta}-Producing Regulatory T Cells from CD4+CD25- Precursors
J. Immunol., October 15, 2002; 169(8): 4183 - 4189.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Yamagiwa, J. D. Gray, S. Hashimoto, and D. A. Horwitz
A Role for TGF-{{beta}} in the Generation and Expansion of CD4+CD25+ Regulatory T Cells from Human Peripheral Blood
J. Immunol., June 15, 2001; 166(12): 7282 - 7289.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. J. Wagar, M. A. Cromwell, L. D. Shultz, B. A. Woda, J. L. Sullivan, R. M. Hesselton, and D. L. Greiner
Regulation of Human Cell Engraftment and Development of EBV-Related Lymphoproliferative Disorders in Hu-PBL-scid Mice
J. Immunol., July 1, 2000; 165(1): 518 - 527.
[Abstract] [Full Text] [PDF]


Home page
Arch Otolaryngol Head Neck SurgHome page
T. Y. Shibuya, W.-Z. Wei, M. Zormeier, J. Ensley, W. Sakr, R. H. Mathog, R. J. Meleca, G. H. Yoo, C. H. June, B. L. Levine, et al.
Anti-CD3/Anti-CD28 Bead Stimulation Overcomes CD3 Unresponsiveness in Patients With Head and Neck Squamous Cell Carcinoma
Arch Otolaryngol Head Neck Surg, April 1, 2000; 126(4): 473 - 479.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Crawford, D. Gabuzda, V. Pantazopoulos, J. Xu, C. Clement, E. Reinherz, and C. A. Alper
Circulating CD2+ Monocytes Are Dendritic Cells
J. Immunol., December 1, 1999; 163(11): 5920 - 5928.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
A. Traynor and R. K. Burt
Haematopoietic stem cell transplantation for active systemic lupus erythematosus
Rheumatology, August 1, 1999; 38(8): 767 - 772.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
P. Youinou and R. Le Corre
The multi-faceted role of transforming growth factor-beta in systemic lupus erythematosus
Lupus, February 1, 1999; 8(2): 87 - 88.
[PDF]


Home page
LupusHome page
K Ohtsuka, J D Gray, M M Stimmler, and D A Horwitz
The relationship between defects in lymphocyte production of transforming growth factor-{beta}1 in systemic lupus erythematosus and disease activity or severity
Lupus, February 1, 1999; 8(2): 90 - 94.
[Abstract] [PDF]


Home page
LupusHome page
K Ohtsuka, J D Gray, F P Quismorio Jr, W Lee, and D A Horwitz
Cytokine-mediated down-regulation of B cell activity in SLE: effects of interleukin-2 and transforming growth factor-beta
Lupus, February 1, 1999; 8(2): 95 - 102.
[Abstract] [PDF]


Home page
J. Immunol.Home page
K. Ohtsuka, J. D. Gray, M. M. Stimmler, B. Toro, and D. A. Horwitz
Decreased Production of TGF-{beta} by Lymphocytes from Patients with Systemic Lupus Erythematosus
J. Immunol., March 1, 1998; 160(5): 2539 - 2545.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.